» Articles » PMID: 34817538

COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed

Overview
Journal JAMA
Specialty General Medicine
Date 2021 Nov 24
PMID 34817538
Citations 18
Authors
Affiliations
Soon will be listed here.
Citing Articles

Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination.

Asamoah-Boaheng M, Grunau B, Haig S, Karim M, Kirkham T, Lavoie P Access Microbiol. 2023; 5(11).

PMID: 38074111 PMC: 10702380. DOI: 10.1099/acmi.0.000678.v3.


A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.

Boulton S, Poutou J, Gill R, Alluqmani N, He X, Singaravelu R Mol Ther Methods Clin Dev. 2023; 31:101110.

PMID: 37822719 PMC: 10562195. DOI: 10.1016/j.omtm.2023.101110.


The societal value of SARS-CoV-2 booster vaccination in Indonesia.

Johnson R, Djaafara B, Haw D, Doohan P, Forchini G, Pianella M Vaccine. 2023; 41(11):1885-1891.

PMID: 36781331 PMC: 9889258. DOI: 10.1016/j.vaccine.2023.01.068.


Association of Lower Antispike Antibody Levels with Mortality in ICU Patients with COVID-19 Disease.

Yelle S, Amte R, Gella V, Mitnala S, Gujjarlapudi D, Ismail M Crit Care Res Pract. 2023; 2023:4174241.

PMID: 36761157 PMC: 9904915. DOI: 10.1155/2023/4174241.


Loss-framing of information and pre-vaccination consultation improve COVID-19 vaccine acceptance: A survey experiment.

Wang K, Wong E, Cheung A, Dong D, Yeoh E Front Public Health. 2023; 11:1063444.

PMID: 36761145 PMC: 9902910. DOI: 10.3389/fpubh.2023.1063444.